Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ascendis Health's share price for the quarter that ended in Jun. 2023 was R0.66. Ascendis Health's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 626 Mil. Therefore, Ascendis Health's market cap for the quarter that ended in Jun. 2023 was R413 Mil.
Ascendis Health's quarterly market cap
increased
from Jun. 2022 (R331 Mil) to Dec. 2022 (R406 Mil) and
increased
from Dec. 2022 (R406 Mil) to Jun. 2023 (R413 Mil).
Ascendis Health's annual market cap
increased
from Jun. 2021 (R279 Mil) to Jun. 2022 (R331 Mil) and
increased
from Jun. 2022 (R331 Mil) to Jun. 2023 (R413 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ascendis Health's Enterprise Value for Today is R435 Mil.
Ascendis Health Market Cap Historical Data
The historical data trend for Ascendis Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Ascendis Health's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Ascendis Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Health's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ascendis Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Ascendis Health's Market Cap falls into.
Ascendis Health Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ascendis Health's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Health (JSE:ASC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ascendis Health Market Cap Related Terms
Thank you for viewing the detailed overview of Ascendis Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Ascendis Health is a drug manufacturer that produces and distributes health products for the human, animal, and plant markets. It has a portfolio of brands and products and owns recognized trademarks in the pharmaceutical and consumer health markets. Ascendis Health has five operating segments: consumer health, pharma, medical, animal health, and biosciences. The pharma division is the contributor to revenue and is further divided into Pharma Africa, Remedica, and Farmalider. Pharma includes generic manufacturing and distribution and over-the-counter medicine manufacturing and distribution. The company's revenue is split between South Africa and Europe and is diversified across currencies, markets, sales channels, and customer groups.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
JSE:ASC has been successfully added to your 